Business Wire1mon
CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union
This follows its approval for the treatment of adults with prurigo nodularis by the United States (U.S.) Food and Drug Administration (FDA) in August 2024. 14 Atopic dermatitis is a common ...
pharmaphorum16d
Dupixent scores a first in rare skin disease prurigo nodularis
Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin ...
WebMD6y
Vitamins by Condition
Considering taking supplements to treat prurigo nodularis? Below is a list of common natural remedies used to treat or reduce the symptoms of prurigo nodularis. Follow the links to read common ...
Hosted on MSN2mon
Galderma Bets on Skin Drug to Turn Around Pharma Business
which is approved for prurigo nodularis and atopic dermatitis among other indications. In September, pharma giant Eli Lilly received approval from the FDA for its Ebglyss drug as a treatment for ...
China Medical System（00867）Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Rα Monoclonal Antibody MG-K10
Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanizedmonoclonal antibody that simultaneously blocks the ...
China Medical System enters collaboration agreement with Mabgeek Biotechnology
China Medical System (CHSYF) entered into a Collaboration Agreement with Hunan Mabgeek Biotechnology and its subsidiary for Class 1 innovative drug anti-IL-4Ralpha humanized monoclonal antibody ...
pharmaphorum3y
Dupixent scores a first in rare skin disease prurigo nodularis
Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin ...